Embla Medical hf (OCSE:EMBLA)
kr 35.3 0.8 (2.32%) Market Cap: 15.07 Bil Enterprise Value: 18.38 Bil PE Ratio: 31.89 PB Ratio: 2.86 GF Score: 71/100

Q4 2022 Ossur hf Earnings Call Transcript

Jan 31, 2023 / 08:00AM GMT
Operator

Good day, and thank you for standing by. Welcome to the Ãssur Q4 and Full Year Results for 2022. (Operator Instructions) Please note that today's conference is being recorded. I would now like to hand over to your first speaker, Mr. Sveinn Solvason, President and CEO. Please go ahead, sir.

Sveinn Solvason;ssur hf.;President;CEO
Ã

&

Thank you very much. I would like to welcome you all to the Ãssur Investor Conference Call where we will cover the results for the fourth quarter and full year 2022. My name is Sveinn Solvason, and I am the President and CEO, and with me here today is Arna Sveinsdottir, our CFO.

We will begin by going through the main topics that impacted the performance in '22, then move into highlights for the quarter and the year, ending with our guidance and a Q&A session.

Can we go to the next slide, please? Despite a challenging external environment, we grew the business in all our regions and business segments. And we'll cover the growth in more detail as we go through

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot